This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Helix, Inc.. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Innovations in Breast Cancer Risk Management by Alexandre Bolze
Introduction
Alexandre Bolze is an innovative inventor based in San Francisco, CA. He has made significant contributions to the field of genetic testing and preventive care for breast cancer. His work focuses on utilizing advanced genetic analysis to improve patient outcomes and risk assessment.
Latest Patents
Bolze holds a patent for a method titled "Dynamic risk management for breast cancer with multi-factor genetic testing." This patent outlines a comprehensive approach to preventive care for breast cancer. The method involves analyzing sequenced genetic data from patients to identify qualifying variants in key genes such as BRCA1, BRCA2, PALB2, ATM, and CHEK2. If a patient does not possess a qualifying variant, the method calculates a polygenic risk score (PRS). Patients with a PRS below a predetermined threshold are classified as low risk for breast cancer. This innovative approach aims to enhance early detection and preventive strategies.
Career Highlights
Bolze is currently employed at Helix, Inc., where he continues to develop and refine his groundbreaking methodologies. His work at Helix emphasizes the importance of genetic testing in personalized medicine and preventive healthcare.
Collaborations
One of his notable collaborators is Joseph J Grzymski, who shares a commitment to advancing genetic research and its applications in healthcare.
Conclusion
Alexandre Bolze's contributions to breast cancer risk management through genetic testing represent a significant advancement in preventive healthcare. His innovative methods have the potential to transform how patients are assessed and treated, ultimately leading to better health outcomes.